Evolent Health, Inc with ticker code (EVH) have now 8 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price High/Low ranges between 63 and 36 and has a mean target at $47.00. Given that the stocks previous close was at $33.95 this would imply there is now a potential upside of 38.4%. There is a 50 day moving average of $32.45 and the 200 moving average now moves to $31.89. The company has a market cap of $3,878m. Company Website: https://www.evolenthealth.com
The potential market cap would be $5,369m based on the market consensus.
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
The company is not paying dividends at this time.
